- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
July 2nd, 2007
Small-cap bio-nanotech company pSivida (PSDV - Cramer's Take - Stockpickr) took off in the opposite direction after announcing that it entered an agreement for a direct offering to sell its Nasdaq-traded American Depositary Shares and warrants to purchase ADSs, including $6.5 million, to Pfizer (PFE - Cramer's Take - Stockpickr - Rating).
It estimates the net proceeds from the offering will be $16.3 million after the placement agent fees and estimated offering expenses. Shares of pSivida were down 32 cents, or 21%, to $1.20.
|Related News Press|
Nanometrics Announces Upcoming Investor Events July 20th, 2016
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers
Ultrasensitive sensor using N-doped graphene July 26th, 2016